Astrocyte Pharmaceuticals Inc.
PrivateLast Round
Grant
Jun 17, 2025
Total Funding Raised
$17.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Astrocyte Pharmaceuticals Inc. is a biotechnology company developing novel neuroprotective therapeutics for the treatment of stroke, traumatic brain injury, concussions, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrocyte Pharmaceuticals Inc. Comparables
Compare Astrocyte Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroTrauma Sciences | 87% | |
| Oxeia Biopharmaceuticals | 87% | |
| TIBEAY Biosciences | 85% |
Astrocyte Pharmaceuticals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| VC Round | Aug 18, 2023 | ||||
| Grant | Sep 16, 2021 | ||||
| Series A | May 3, 2021 | ||||
| Grant | Sep 19, 2018 | ||||
Grant | Sep 18, 2018 |
Astrocyte Pharmaceuticals Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | VC Round, Series A, Seed |
| Dreavent Capital | VC Round |
| Nest.Bio | Seed |
| CR Ventures | Series A |
| NIH RADx | Grant |
| DeepWork Capital | VC Round, Series A |
| BrightFocus Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 139% MoM, reaching 2.9K.
- Jun 17, 2025
$3M grant awarded by NIH RADx.
Astrocyte Pharmaceuticals Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Astrocyte Pharmaceuticals Inc.'s valuation, stock price, and market status.
Is Astrocyte Pharmaceuticals Inc. a public or private company?
Astrocyte Pharmaceuticals Inc. is a private company.
What is the current stock price of Astrocyte Pharmaceuticals Inc.?
Astrocyte Pharmaceuticals Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Astrocyte Pharmaceuticals Inc. worth (valuation)?
Valuation information for Astrocyte Pharmaceuticals Inc. is not publicly available.
Can I buy Astrocyte Pharmaceuticals Inc. stock?
Astrocyte Pharmaceuticals Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Astrocyte Pharmaceuticals Inc.'s last funding round?
Astrocyte Pharmaceuticals Inc.'s most recent funding round was Grant on June 17, 2025.
Who are the main investors in Astrocyte Pharmaceuticals Inc.?
Key investors in Astrocyte Pharmaceuticals Inc. include Dreavent Capital, Boston Harbor Angels.
Will Astrocyte Pharmaceuticals Inc. IPO soon?
No public IPO plans have been announced for Astrocyte Pharmaceuticals Inc..
How can I track Astrocyte Pharmaceuticals Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Astrocyte Pharmaceuticals Inc.'s secondary market activity and sign up for updates.